Related Experiment Videos
Promoting apoptosis: a novel activity associated with the cyclin-dependent kinase inhibitor p27
Y Katayose1, M Kim, A N Rakkar
1Medicine Branch, Division of Clinical Sciences, National Cancer Institute, NIH, Bethesda, Maryland 20892, USA.
Abstract:
p27Kip1, a cyclin-dependent kinase inhibitor, is recognized as a negative regulator of the cell cycle. In this paper, we report that overexpression of p27Kip1 triggers apoptosis in several different human cancer cell lines. Using a recombinant adenoviral vector that expresses p27Kip1 (Adp27), we found that overexpression of p27Kip1 in MDA-MB-231 breast cancer cells induces apoptosis that was seen by a number of different techniques, including flow cytometry and in situ terminal deoxynucleotidyl transferase-mediated nick end labeling, flow cytometric assay for sub-G1 population, and 4',6-diamindino-2-phenylindole staining. Cleavage of poly(ADP-ribose) polymerase and degradation of cyclin B1, events that are known to be associated with apoptosis, were also observed following overexpression of p27Kip1. This is the first report indicating a role for p27Kip1 in induction of apoptosis.
Insights
Overexpression of p27Kip1, a cell cycle inhibitor, triggers apoptosis in human cancer cells. This study reveals a novel role for p27Kip1 in inducing programmed cell death, offering new therapeutic insights.
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Research
Background:
- p27Kip1 functions as a negative regulator of the cell cycle.
- The role of p27Kip1 in apoptosis induction has not been previously established.
Purpose of the Study:
- To investigate the potential role of p27Kip1 in triggering apoptosis in human cancer cell lines.
- To explore the mechanism by which p27Kip1 overexpression affects cancer cell viability.
Main Methods:
- Utilized a recombinant adenoviral vector (Adp27) for p27Kip1 overexpression.
- Employed techniques such as flow cytometry, in situ terminal deoxynucleotidyl transferase-mediated nick end labeling (TUNEL), and 4',6-diamidino-2-phenylindole (DAPI) staining.
- Monitored key apoptotic markers including poly(ADP-ribose) polymerase (PARP) cleavage and cyclin B1 degradation.
Main Results:
- Overexpression of p27Kip1 successfully induced apoptosis in MDA-MB-231 breast cancer cells.
- Apoptosis was confirmed through multiple assays, including cell cycle analysis (sub-G1 population) and DNA fragmentation.
- Biochemical evidence of apoptosis, such as PARP cleavage and cyclin B1 degradation, was observed.
Conclusions:
- p27Kip1 overexpression is capable of inducing apoptosis in human cancer cells.
- This study provides the first evidence for p27Kip1's direct role in initiating programmed cell death.
- These findings suggest p27Kip1 as a potential therapeutic target for cancer treatment.